Lecanemab for Patients With Early Alzheimer Disease
Donald A. Berry(Berry & Associates (United States)), Scott Berry(Queen's University), Chad J. Swanson(Eisai (United States)), David Li(Angion (United States)), Michael C. Irizarry(Eisai (United States)), Michio Kanekiyo(Eisai (United States)), Lynn D. Kramer(Eisai (United States)), Shobha Dhadda(Eisai (United States))
Cited by 21
Related Papers
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
|Nature Neuroscience|1999|938